Ara
Toplam kayıt 36, listelenen: 21-30
Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study
(Sage Publications Ltd, 2022)
Introduction: Ado-trastuzumab emtansine (T-DM1) is an antibody-drug conjugate and its survival advantage has been shown in advanced human epidermal growth factor receptor 2 (HER2)-positive breast cancer. However, clinical ...
Vitamin D Deficiency Might Contribute Fatigue and Disease Activity in Patients with Fibromyalgia
(Bmj Publishing Group, 2015)
[No Abstract Available]
Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study
(Springer, 2021)
Background The new second-generation tyrosine kinase inhibitors (TKIs) have superior survival outcome and worse toxicity profile when compared with first-generation TKIs according to the results of clinical trials. However, ...
Mindfulness Among Medical Oncology Doctors and Its Relation With Burnout: Turkish Oncology Group (TOG) Study
(Lippincott Williams & Wilkins, 2021)
PURPOSE: Medical oncology physicians have been identified as one of the main risk groups for the development of burnout. Mindfulness as being aware of the moment nonjudgmentally seems to be a protective factor against ...
Breast cancer in young and very young women; Is age related to outcome?
(Wolters Kluwer Medknow Publications, 2021)
Background: Breast cancer in young women is associated with aggressive biology. We analyzed histopathological and clinical properties of breast cancer patients diagnosed at <= 40 years of age. Methods: Breast cancer patients ...
A new predictive marker for predicting response after neoadjuvant chemotherapy in hormone receptor positive/HER2-negative patients: a logarithmic model
(Zerbinis Publications, 2021)
Purpose: Estrogen receptor (ER) and progesterone receptor (PgR) levels as well as Ki-67 expression levels are independent predictive markers in patients with hormone receptor-positive breast cancer. In this study, we ...
The most-cited articles in geriatric oncology: A bibliometric analysis
(Termedia Publishing House Ltd., 2021)
Introduction: We conducted a bibliometric analysis to determine the most impactful articles in the oncologic management of elderly cancer patients. Material and methods: We searched Web of Science papers with six keywords: ...
The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study
(Lippincott Williams & Wilkins, 2022)
In our study, we aimed to evaluate the pathological response rates and side effect profile of adding pertuzumab to the treatment of HER2+ locally advanced, inflammatory, or early-stage breast cancer. This study was conducted ...
Neoadjuvan Kemoterapi Alan Meme Kanseri Hastalarında COVID-19 Pandemisinin Tanı ve Tedavi Sürecine Etkileri
(2021)
Amaç: Bu çalışmamızda neoadjuvan kemoterapi alan meme kanseri hastalarında pandeminin tanı-tedavi sürecine etkisini araştırdık.Gereç ve Yöntem: Koronavirüs hastalığı-2019 (COVID-19) pandemisi dönemindeki bir yıl ile pandemi ...
Soluble B7H3 level in breast cancer and its relationship with clinicopathological variables and T-cell infiltration
(Termedia Publishing House Ltd, 2022)
Aim of the study Although early diagnosis of breast cancer (BC) is often associated with a good prognosis, there is currently no biomarker with high sensitivity serving this purpose. B7H3, a recently identified member of ...